Hims & Hers Health, Inc. is a consumer-focused digital health and wellness company that operates a multi-specialty telehealth platform. The firm connects individuals with licensed healthcare professionals through its websites and mobile applications, enabling convenient access to medical consultations and, when appropriate, prescription therapies and personalized treatment plans. Its platform spans key areas such as sexual health, hair care, dermatology, mental health, hormone and primary care, and weight loss, complemented by comprehensive laboratory testing and curated non-prescription wellness products, supplements, and personal care items. Hims & Hers Health, Inc. uses a direct-to-consumer, largely subscription-based model, with medications fulfilled via licensed pharmacies and over-the-counter products sold through its digital storefronts. The company serves customers primarily in the United States, with additional reach in markets such as the United Kingdom and Canada, positioning itself as an accessible, digital-first alternative to traditional healthcare for adults seeking discreet and convenient care. Founded in 2017 and headquartered in San Francisco, California, Hims & Hers Health, Inc. today plays a notable role in the telehealth and online pharmacy segments of the healthcare market.
Website2269 Chestnut Street
San Francisco, CA, 94123
United States
Key Stats for HIMS Stock52-Week Range: $14 to $65Market Cap: around $6. 9 billionStreet Mean Target: around $31Forward 2-Year Revenue Growth (CAGR): around 30%Forward 2-Year EPS Growth (CAGR): around 18%NTM P/E: around 23xLTM Gross Margin: 69.
Hims & Hers Health has delivered a very strong multi year share price move, and that run now puts fresh attention on whether the current valuation can be supported by its sales base. With recent headlines around new products and regulatory scrutiny, the question is how much of that is already reflected in what investors are paying for each dollar of revenue. Over the past 3 years, Hims & Hers Health has returned about 3.7x for shareholders, which puts significant weight on whether its...
Investors talking about HIMS also mention
| # | Name | Attention |
|---|---|---|
| 1 | Oscar Health, Inc.OSCR | 0.05%+0.02 |
| 2 | Novo Nordisk A/S Sponsored ADRNVO | 0.14%-0.03 |
| 3 | LifeMD, Inc.LFMD | 0%0 |
| 4 | Duolingo, Inc. Class A Common StockDUOL | 0%-0.01 |
| 5 | Celsius Holdings IncCELH | 0.01%-0.06 |
| 6 | AST SpaceMobile Inc.ASTS | 2.36%+0.89 |
| 7 | Eli Lilly and CompanyLLY | 0.15%+0.07 |
| 8 | Super Micro Computer Inc.SMCI | 0.1%+0 |
| 9 | IREN Ltd.IREN | 1.1%-0.14 |
| 10 | Zeta Global Holdings Corp.ZETA | 0%-0.03 |
What share of all stock conversation is about HIMS?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0.17% +0.1 | 0.28% +0.11 | 0.31% -0.03 | 0.46% -0.31 |
Of the messages about HIMS that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | 97.43% +35.81 | 88.9% +4.47 | 87.03% +8.15 | 75.13% -6.87 | ||
| Bearish | 2.57% -35.81 | 11.1% -4.47 | 12.97% -8.15 | 24.87% +6.87 |
Of the messages about HIMS that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Earnings | 41.46% | 7.42% | 13.03% | 10.11% | ||
| Announcements | 1.95% | 26.56% | 19.38% | 8.79% | ||
| Analysts | 0% | 12.23% | 15.45% | 23.17% | ||
| Technical Analysis | 49.27% | 40.64% | 35.77% | 9.43% | ||
| Macro | 5.85% | 12.95% | 14.75% | 46.12% | ||
| Controversies | 1.46% | 0.21% | 1.61% | 2.38% |
Of the messages about HIMS, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | 87.73% | 76.7% | 43.96% | 68.1% | ||
| Newcomers | 12.27% | 23.3% | 56.04% | 31.9% |